Catharina Larsson

Title: Catharina Larsson: Innovator in Medical Research

Introduction

Catharina Larsson is a prominent inventor based in Stockholm, Sweden. She has made significant contributions to the field of medical research, particularly in the areas of cervical dysplasia and vascular biology. With a total of 2 patents, her work has the potential to impact diagnostics and therapeutics significantly.

Latest Patents

One of her latest patents is a method for detecting the risk of progression of low-grade cervical dysplasia. This invention provides methods for identifying conditions of low-grade cervical dysplasia and assessing the progressive potential of individual lesions to develop into high-grade cervical dysplasia, cervical squamous cell cancer, and cervical adenocarcinoma. Another notable patent involves vascular endothelial growth factor polypeptides. This invention relates to an isolated molecule having vascular endothelial growth factor-like properties and a genetic sequence encoding it. The molecule is useful in developing a range of therapeutics and diagnostics for conditions requiring enhanced or diminished vasculature and vascular permeability.

Career Highlights

Throughout her career, Catharina has worked with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and the Ludwig Institute for Cancer Research Limited. Her work in these institutions has allowed her to advance her research and contribute to significant medical advancements.

Collaborations

Catharina has collaborated with notable colleagues, including Thomas Ried and Kerstin Heselmeyer-Haddad. These collaborations have further enriched her research and expanded the impact of her inventions.

Conclusion

Catharina Larsson is a remarkable inventor whose work in medical research has the potential to transform diagnostics and treatment options. Her innovative patents reflect her dedication to improving healthcare outcomes.